PTGS2 and liver cancer: Previous studies have shown that in liver cancer cells, SSD may inhibit the expression of COX-2 through the P-STAT3/HIF-1α pathway and reduce the expressions of P-STAT3 and HIF-1α, which inhibits the proliferation of HCC SMMC-7721 cells[44].